๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A phase II study of oral weekly 4-demethoxydaunorubicin in advanced breast cancer

โœ Scribed by Smith, David B.; Howell, Anthony

Book ID
121928700
Publisher
Elsevier Science
Year
1987
Weight
427 KB
Volume
23
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase II study of oral idarubicin (4-d
A phase II study of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer
โœ Nicholas S. A. Stuart; Michael H. Cullen; Terrence J. Priestman; George R. P. Bl ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer ๐ŸŒ English โš– 352 KB

Idarubicin (4-demethoxydaunorubicin: DMDNR) is an orally active analogue of daunorubicin that has shown promising activity in animal and early clinical studies. We gave idarubicin in a phase II study to patients with advanced breast cancer unresponsive to hormonal manipulation and in some cases to s